Anna Elizabeth Nicola Ferrera Baumann, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 880 Alder Ave Fl 2, Incline Village, NV 89451 Phone: 775-831-6200 Fax: 775-888-4239 |
Dr. Daniel L Peterson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 926 Incline Way, Unit 150, Incline Village, NV 89451 Phone: 775-832-0989 Fax: 775-832-3046 |
News Archive
Cambridge Research & Instrumentation, Inc. (CRi), a leader in multicolor imaging solutions for preclinical and clinical research, today announced the newest addition to the award-winning Nuanceā¢ multispectral imaging product family for multicolor tissue and cell-based imaging. The TRIO system is compact, multipurpose and affordable, offering a simplified interface and versatile design to fit any microscope with a camera-mount.
LodgeNet Interactive Corporation today reported annual 2010 revenue of $452.2 million compared to $484.5 million in 2009. Net loss attributable to common stockholders was $(17.4) million or $(0.71) per share (basic and diluted) for 2010 compared to $(13.3) million or $(0.59) per share (basic and diluted) for 2009.
Time-lapsed video of individual breast tissue cells reveals a never-before-seen event in the life of a cell: a protein that cycles between two major compartments in the cell. The results give researchers a more complete view of the internal signals that cause breast tissue cells to grow, events that go awry in cancer and are targets of drug development.
The U.N. General Assembly opened its 65th session on Tuesday in New York with the incoming Assembly President Joseph Deiss, former Swiss foreign minister, calling for the focus of the upcoming year to be prioritizing efforts to achieve the U.N. Millennium Development Goals (MDGs), reaffirming the role of the U.N. in global governance and promoting sustainable development, Xinhua reports (9/15).
In an effort to find ways to improve long-term outcomes for people with opioid use disorder, University of Massachusetts Amherst epidemiology researcher Elizabeth Evans set out to study the obstacles to treating this chronic condition with an effective medication, buprenorphine-naloxone.
› Verified 1 days ago